PL3016675T3 - Roztwór ochronny do zapobiegania lub ograniczania zespołu poreperfuzyjnego mózgu i całego organizmu - Google Patents

Roztwór ochronny do zapobiegania lub ograniczania zespołu poreperfuzyjnego mózgu i całego organizmu

Info

Publication number
PL3016675T3
PL3016675T3 PL14735554T PL14735554T PL3016675T3 PL 3016675 T3 PL3016675 T3 PL 3016675T3 PL 14735554 T PL14735554 T PL 14735554T PL 14735554 T PL14735554 T PL 14735554T PL 3016675 T3 PL3016675 T3 PL 3016675T3
Authority
PL
Poland
Prior art keywords
brain
preventing
whole body
reperfusion injury
protective solution
Prior art date
Application number
PL14735554T
Other languages
English (en)
Inventor
Christoph Benk
Friedhelm Beyersdorf
Georg Trummer
Original Assignee
Resuscitec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resuscitec Gmbh filed Critical Resuscitec Gmbh
Publication of PL3016675T3 publication Critical patent/PL3016675T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14735554T 2013-07-05 2014-07-01 Roztwór ochronny do zapobiegania lub ograniczania zespołu poreperfuzyjnego mózgu i całego organizmu PL3016675T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13175243.8A EP2821081A1 (en) 2013-07-05 2013-07-05 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body
EP14735554.9A EP3016675B1 (en) 2013-07-05 2014-07-01 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body
PCT/EP2014/063905 WO2015000871A1 (en) 2013-07-05 2014-07-01 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body

Publications (1)

Publication Number Publication Date
PL3016675T3 true PL3016675T3 (pl) 2017-12-29

Family

ID=48782915

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14735554T PL3016675T3 (pl) 2013-07-05 2014-07-01 Roztwór ochronny do zapobiegania lub ograniczania zespołu poreperfuzyjnego mózgu i całego organizmu

Country Status (10)

Country Link
US (2) US10695407B2 (pl)
EP (2) EP2821081A1 (pl)
JP (1) JP6389518B2 (pl)
KR (1) KR102244530B1 (pl)
CN (1) CN105246502A (pl)
ES (1) ES2640383T3 (pl)
HK (1) HK1213819A1 (pl)
PL (1) PL3016675T3 (pl)
RU (1) RU2672558C2 (pl)
WO (1) WO2015000871A1 (pl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US7288551B1 (en) * 2000-09-19 2007-10-30 Charlotte-Mecklenburg Hospital Authority Solution for the preservation of hearts
DE60121027T3 (de) * 2000-11-03 2011-06-09 Xvivo Perfusion Ab Lösung zur evaluierung und konservierung
DE10262084B4 (de) * 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
GB0403509D0 (en) * 2004-02-17 2004-03-24 Neuro Targets Ltd Galanin receptors and brain injury
GB0612877D0 (en) 2006-06-29 2006-08-09 Univ Edinburgh Organ preservation solution
CN101721688B (zh) * 2008-10-13 2012-07-04 首都医科大学宣武医院 基于神经介入微导管技术的脑保护灌注液及其制备方法
KR20120050442A (ko) 2009-07-10 2012-05-18 쓰롬보제닉스 엔.브이. 플라스미노겐 및 플라스민의 변이체
US8288084B2 (en) * 2009-07-12 2012-10-16 Revive Organtech, Inc. Composition and method for flushing and cold/cryo preserving organs, tissues, and cells
DE102009045589A1 (de) 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
RU202597U1 (ru) * 2020-08-11 2021-02-26 Общество с ограниченной ответственностью "Информационные технологии" (ООО "ИнфоТех") Устройство магнитной цепи для обнаружения и последующего снижения напряженности магнитного поля в зазоре изолирующего стыка

Also Published As

Publication number Publication date
EP3016675B1 (en) 2017-08-16
CN105246502A (zh) 2016-01-13
KR20160030191A (ko) 2016-03-16
EP3016675A1 (en) 2016-05-11
BR112015029121A2 (pt) 2017-07-25
ES2640383T3 (es) 2017-11-02
WO2015000871A1 (en) 2015-01-08
US11185574B2 (en) 2021-11-30
US20200276277A1 (en) 2020-09-03
JP2016523876A (ja) 2016-08-12
US20160367643A1 (en) 2016-12-22
EP2821081A1 (en) 2015-01-07
RU2016103656A (ru) 2017-08-10
KR102244530B1 (ko) 2021-04-27
JP6389518B2 (ja) 2018-09-12
HK1213819A1 (zh) 2016-07-15
RU2016103656A3 (pl) 2018-05-29
US10695407B2 (en) 2020-06-30
RU2672558C2 (ru) 2018-11-16

Similar Documents

Publication Publication Date Title
IL264541B (en) The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b
HRP20181863T1 (hr) Derivati sulfamoiltiofenamida i njihova uporaba kao lijekova za liječenje hepatitisa b
HRP20170945T1 (hr) Sulfamoil-arilamidi i njihova uporaba kao lijekova za liječenje hepatitisa b
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
HK1217330A1 (zh) -苯基-氨甲酰衍生物及其作爲藥物用於治療乙型肝炎的用途
HK1209424A1 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury
EP2986113A4 (en) Compositions and methods for the treatment of brain injury
HK1213819A1 (zh) 用於防止或減少腦和全身再灌注損傷的保護液
EP2981324A4 (en) METHODS AND ARTICLES MANUFACTURED FOR THE TREATMENT OF SKIN
AP2015008814A0 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b